The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical markers of successful liquid biopsy-based genomic profiling in veterans with prostate cancer.
 
Aixia Guo
No Relationships to Disclose
 
Sara Ahmed
Employment - PierianDx
Leadership - PierianDx
Stock and Other Ownership Interests - PierianDx
 
Kerry Rowe
No Relationships to Disclose
 
Colin C. Pritchard
Consulting or Advisory Role - AstraZeneca; Sana Biotechnology
Research Funding - Color Genomics (I)
 
Robert B. Montgomery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Michael J. Kelley
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Novartis (Inst); Regeneron (Inst)
Other Relationship - IBM (Inst)
 
Matthew Rettig
Stock and Other Ownership Interests - ARavalent; Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson